Anticancer effects of salvianolic acid A through multiple signaling pathways (Review)
- Authors:
- Cheng-Xia Li
- Qi Xu
- Shi-Ting Jiang
- Dan Liu
- Chao Tang
- Wen-Li Yang
-
Affiliations: Institute for Cancer Medicine, School of Basic Medicine Sciences, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China - Published online on: April 17, 2025 https://doi.org/10.3892/mmr.2025.13541
- Article Number: 176
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Organization GWH, . Global Breast Cancer Initiative Implementation Framework: Assessing, strengthening and scaling-up of services for the early detection and management of breast cancer. CC BY-NC-SA 3.0 IGO. 2023. | |
|
Xin J, Song M, Liu X, Zou H, Wang J, Xiao L, Jia Y, Zhang G, Jiang W, Lei M, et al: A new strategy of using low-dose caffeic acid carbon nanodots for high resistance to poorly differentiated human papillary thyroid cancer. J Nanobiotechnology. 22:5712024. View Article : Google Scholar : PubMed/NCBI | |
|
Diefenhardt M, Martin D, Hofheinz RD, Ghadimi M, Fokas E, Rödel C and Fleischmann M: Persistent lymph node metastases after neoadjuvant chemoradiotherapy for rectal cancer. JAMA Netw Open. 7:e24329272024. View Article : Google Scholar : PubMed/NCBI | |
|
Guo J, Chen X, Wu M, Wang D, Zhao Y, Li Q, Tang G, Che F, Xia Z, Liang Z, et al: Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: A multicentre, randomised, placebo-controlled, double-blind, clinical trial. Lancet. 404:2187–2196. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Huang W, Wang J, Kuang M, Xiao Z, Fan B, Sun G and Tan Z: Exploring global research status and trends in anti-obesity effects of traditional Chinese medicine through intestinal microbiota: A bibliometric study. Front Cell Infect Microbiol. 13:12714732023. View Article : Google Scholar : PubMed/NCBI | |
|
Fan Y, Liu J, Miao J, Zhang X, Yan Y, Bai L, Chang J, Wang Y, Wang L, Bian Y and Zhou H: Anti-inflammatory activity of the Tongmai Yangxin pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway. J Ethnopharmacol. 276:1141062021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Fang C, Luo J, Gong C, Wang L and Zhu S: Traditional Chinese medicine for cancer treatment. Am J Chin Med. 52:583–604. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Wang S, Wang N, Zheng Y, Yang B, Wang X, Zhang J, Pan B and Wang Z: Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration. Cell Commun Signal. 19:892021. View Article : Google Scholar : PubMed/NCBI | |
|
Yan X, Yao C, Fang C, Han M, Gong C, Hu D, Shen W, Wang L, Li S and Zhu S: Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci. 18:585–598. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Man S, Liu W, Bi J, Bai J, Wu Q, Hu B, Hu J and Ma L: Smart mesoporous silica nanoparticles loading curcumin inhibit liver cancer. J Agric Food Chem. 72:25743–25754. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Islam MS, Wang C, Zheng J, Paudyal N, Zhu Y and Sun H: The potential role of tubeimosides in cancer prevention and treatment. Eur J Med Chem. 162:109–121. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ma J, Wang J, Wan Y, Wang S and Jiang C: Probiotic-fermented traditional Chinese herbal medicine, a promising approach to maintaining the intestinal microecology. J Ethnopharmacol. 337:1188152024. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou L, Zuo Z and Chow MS: Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 45:1345–1359. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jia Y, Yao D, Bi H, Duan J, Liang W, Jing Z and Liu M: Salvia miltiorrhiza Bunge (Danshen) based nano-delivery systems for anticancer therapeutics. Phytomedicine. 128:1555212024. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Zhang J, Sun C, Yang R, Sheng M, Hu J, Kai G and Han B: Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms. J Ethnopharmacol. 318:1170222024. View Article : Google Scholar : PubMed/NCBI | |
|
Shan XX, Hong BZ, Liu J, Wang GK, Chen WD, Yu NJ, Peng DY, Wang L and Zhang CY: Review of chemical composition, pharmacological effects, and clinical application of Salviae Miltiorrhizae Radix et Rhizoma and prediction of its Q-markers. Zhongguo Zhong Yao Za Zhi. 46:5496–5511. 2021.(In Chinese). PubMed/NCBI | |
|
Zhang J, Jin Q, Deng Y, Hou J, Wu W and Guo D: New depsides from the roots of Salvia miltiorrhiza and their radical-scavenging capacity and protective effects against H2O2-induced H9c2 cells. Fitoterapia. 121:46–52. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
National Center for Biotechnology Information, . ‘PubChem Compound Summary for CID 5281793. Salvianolic acid A’ PubChem; https://pubchem.ncbi.nlm.nih.gov/compound/Salvianolic-acid-A2–January. 2024 | |
|
Zhao H, Han B, Li X, Sun C, Zhai Y, Li M, Jiang M, Zhang W, Liang Y and Kai G: Salvia miltiorrhiza in breast cancer treatment: A review of its phytochemistry, derivatives, nanoparticles, and potential mechanisms. Front Pharmacol. 13:8720852022. View Article : Google Scholar : PubMed/NCBI | |
|
Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, et al: PubChem 2023 update. Nucleic Acids Res. 51:D1373–D1380. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Diao HY, Zhu W, Liu J, Yin S, Wang JH and Li CL: Salvianolic acid a improves rat kidney injury by regulating MAPKs and TGF-β1/Smads signaling pathways. Molecules. 28:36302023. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang HF, Wang YL, Gao C, Gu YT, Huang J, Wang JH, Wang JH and Zhang Z: Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats. Acta Pharmacol Sin. 39:1855–1864. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Li D, Wang T, Li Y, Qin P, Zhu H, Zhang M, Li W, Yu L, Duan H, et al: Salvianolic acid A inhibits pseudorabies virus infection by directly inactivating the virus particle. Phytomedicine. 134:1560152024. View Article : Google Scholar : PubMed/NCBI | |
|
Meirelles LEF, Souza MVF, Carobeli LR, Morelli F, Mari NL, Damke E, Shinobu Mesquita CS, Teixeira JJV, Consolaro MEL and Silva VRSD: Combination of conventional drugs with biocompounds derived from cinnamic acid: A promising option for breast cancer therapy. Biomedicines. 11:2752023. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang H, Wang S, Liu Y, Zheng C, Chen L, Zheng K, Xu Z, Dai Y, Jin H, Cheng Z, et al: Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma. Discov Oncol. 14:642023. View Article : Google Scholar : PubMed/NCBI | |
|
Yang LL, Li DY, Zhang YB, Zhu MY, Chen D and Xu TD: Salvianolic acid A inhibits angiotensin II-induced proliferation of human umbilical vein endothelial cells by attenuating the production of ROS. Acta Pharmacol Sin. 33:41–48. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong W, Sun B, Gao W, Qin Y, Zhang H, Huai L, Tang Y, Liang Y, He L, Zhang X, et al: Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction. EBioMedicine. 37:246–258. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Pu XY, Mei Y, Zheng Q and Ko CY: Inhibition of melanoma cell growth by salvianolic acid A through CHK2-CDC25A pathway modulation. Front Biosci (Landmark Ed). 29:2132024. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng X, Chen S, Yang Q, Cai J, Zhang W, You H, Xing J and Dong Y: Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2. Cancer Biol Ther. 16:1407–1414. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Qin X, Guo J, Li H, He H, Cai F, Chen X, Chen M, Chen T and Ma L: Selenium electrophilic center responsive to biological electron donors for efficient chemotherapy. Adv Sci (Weinh). e24120622025. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao M, Jiang X, Fang J, Lin Y, Li Y, Pei R, Ye P, Lu Y and Jiang L: The kava chalcone flavokawain B exerts inhibitory activity and synergizes with BCL-2 inhibition in malignant B-cell lymphoma. Phytomedicine. 120:1550742023. View Article : Google Scholar : PubMed/NCBI | |
|
Hseu YC, Huang YC, Thiyagarajan V, Mathew DC, Lin KY, Chen SC, Liu JY, Hsu LS, Li ML and Yang HL: Anticancer activities of chalcone flavokawain B from Alpinia pricei Hayata in human lung adenocarcinoma (A549) cells via induction of reactive oxygen species-mediated apoptotic and autophagic cell death. J Cell Physiol. 234:17514–17526. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Dong J, Xu J, Qian Y, Chen D, Fan Z, Yang H, Xiang J, Xue X, Luo X, et al: Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway. Biochem Pharmacol. 223:1161122024. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang S, Wang P, Sun X, Zhang M, Zhang S, Cao Y, Wang Y, Liu L and Gao X: Mechanistic study of leukopenia treatment by Qijiao shengbai Capsule via the Bcl2/Bax/CASAPSE3 pathway. Front Pharmacol. 15:14515532024. View Article : Google Scholar : PubMed/NCBI | |
|
Ye C, Yao Z, Wang Y and Zhang C: Asiaticoside promoted ferroptosis and suppressed immune escape in gastric cancer cells by downregulating the Wnt/β-catenin pathway. Int Immunopharmacol. 134:1121752024. View Article : Google Scholar : PubMed/NCBI | |
|
Shin N, Lee HJ, Sim DY, Ahn CH, Park SY, Koh W, Koh J, Koh BS, Koh B and Koh SH: Anti-warburg mechanism of ginsenoside F2 in human cervical cancer cells via activation of miR193a-5p and inhibition of β-Catenin/c-Myc/hexokinase 2 signaling axis. Int J Mol Sci. 25:94182024. View Article : Google Scholar : PubMed/NCBI | |
|
Nilkhet S, Vongthip W, Lertpatipanpong P, Prasansuklab A, Tencomnao T, Chuchawankul S and Baek SJ: Ergosterol inhibits the proliferation of breast cancer cells by suppressing AKT/GSK-3beta/beta-catenin pathway. Sci Rep. 14:196642024. View Article : Google Scholar : PubMed/NCBI | |
|
Pan C, Xu Y, Jiang Z, Fan C, Chi Z, Zhang Y, Miao M, Ren Y, Wu Z, Xu L, et al: Naringenin relieves paclitaxel-induced pain by suppressing calcitonin gene-related peptide signalling and enhances the anti-tumour action of paclitaxel. Br J Pharmacol. 18:3136–3159. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Lin WS, Leland JV, Ho CT and Pan MH: Occurrence, bioavailability, anti-inflammatory, and anticancer effects of pterostilbene. J Agric Food Chem. 68:12788–12799. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Xu C, Weng W and Goel A: Combined treatment with Aronia berry extract and oligomeric proanthocyanidins exhibit a synergistic anticancer efficacy through LMNB1-AKT signaling pathways in colorectal cancer. Mol Carcinog. 63:2145–2157. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Szoka L, Stocki M and Isidorov V: Dammarane-Type 3,4-seco-triterpenoid from silver birch (Betula pendula Roth) buds induces melanoma cell death by promotion of apoptosis and autophagy. Molecules. 29:40912024. View Article : Google Scholar : PubMed/NCBI | |
|
Cai J, Chen S, Zhang W, Zheng X, Hu S, Pang C, Lu J, Xing J and Dong Y: Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway. Phytomedicine. 21:1725–1732. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fang CY, Wu CZ, Chen PN, Chang YC, Chuang CY, Lai CT, Yang SF and Tsai LL: Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway. Environ Toxicol. 33:545–554. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Pei R, Si T, Lu Y, Zhou JX and Jiang L: Salvianolic acid A, a novel PI3K/Akt inhibitor, induces cell apoptosis and suppresses tumor growth in acute myeloid leukemia. Leuk Lymphoma. 59:1959–1967. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Péczka N, Orgován Z, Ábrányi-Balogh P and Keserű GM: Electrophilic warheads in covalent drug discovery: An overview. Expert Opin Drug Discov. 17:413–422. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng M, Zhang Y, Xu Y, Han Y, Wu Y and Kang J: Chemoproteomics and phosphoproteomics profiling reveals salvianolic acid a as a covalent inhibitor of mTORC1. J Proteome Res. 22:2450–2459. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Yin X, Feng Y and Kang W: Effect of salvianolic acid A on the proliferation and apoptosis in esophageal cancer cells and the underlying mechanisms. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 45:1269–1275. 2020.(In English, Chinese). PubMed/NCBI | |
|
Wang X, Wang C, Zhang L, Li Y, Wang S, Wang J, Yuan C, Niu J, Wang C and Lu G: Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells. Anticancer Drugs. 26:210–223. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tang XL, Yan L, Zhu L, Jiao DM, Chen J and Chen QY: Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway. J Pharmacol Sci. 135:1–7. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, Xu J, Li D, Chen J, Shen X, Xu F, Teng F, Deng Y, Ma H, Zhang L, et al: Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice. Phytomedicine. 21:1137–1145. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li T, Kong AN, Ma Z, Liu H, Liu P, Xiao Y, Jiang X and Wang L: Protein arginine methyltransferase 1 may be involved in pregnane × receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant. Oncotarget. 7:20236–20248. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kebebe D, Wu Y, Zhang B, Yang J, Liu Y, Li X, Ma Z, Lu P, Liu Z and Li J: Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer. Int J Nanomedicine. 14:6179–6195. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Zhang L, La X, Li Z, Li H and Guo S: Salvianolic acid A inhibits tumor-associated angiogenesis by blocking GRP78 secretion. Naunyn Schmiedebergs Arch Pharmacol. 392:467–480. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang SH, Su J and Zhen YS: Salvianolic acid A inhibits nucleoside transport and potentiates the antitumor activity of chemotherapeutic drugs. Yao Xue Xue Bao. 39:496–499. 2004.(In Chinese). PubMed/NCBI | |
|
D'Arcy MS: Cell death: A review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011. View Article : Google Scholar : PubMed/NCBI | |
|
Singh SP, Pathuri G, Asch AS, Rao CV and Madka V: Stat3 inhibitors TTI-101 and SH5-07 suppress bladder cancer cell survival in 3D tumor models. Cells. 13:14632024. View Article : Google Scholar : PubMed/NCBI | |
|
Shaban NZ, Hegazy WA, Abu-Serie MM, Talaat IM, Awad OM and Habashy NH: Seedless black Vitis vinifera polyphenols suppress hepatocellular carcinoma in vitro and in vivo by targeting apoptosis, cancer stem cells, and proliferation. Biomed Pharmacother. 175:1166382024. View Article : Google Scholar : PubMed/NCBI | |
|
Thinnes FP: Neuroendocrine differentiation of LNCaP cells suggests: VDAC in the cell membrane is involved in the extrinsic apoptotic pathway. Mol Genet Metab. 97:241–243. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Conti Nibali S, De Siervi S, Luchinat E, Magrì A, Messina A, Brocca L, Mantovani S, Oliviero B, Mondelli MU, De Pinto V, et al: VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference. iScience. 27:1098532024. View Article : Google Scholar : PubMed/NCBI | |
|
Kulyar MF, Mo Q, Yao W, Li Y, Nawaz S, Loon KS, Ahmed AE, Alsaegh AA, Al Syaad KM, Akhtar M, et al: Modulation of apoptosis and Inflammasome activation in chondrocytes: Co-regulatory role of Chlorogenic acid. Cell Commun Signal. 22:22024. View Article : Google Scholar : PubMed/NCBI | |
|
Van Opdenbosch N and Lamkanfi M: Caspases in cell death, inflammation, and disease. Immunity. 50:1352–1364. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Soengas MS, Alarcón RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW: Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 284:156–159. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Pettigrew CA and Cotter TG: Deregulation of cell death (apoptosis): Implications for tumor development. Discov Med. 8:61–63. 2009.PubMed/NCBI | |
|
Carneiro BA and El-Deiry WS: Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 17:395–417. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Peng H, Yuan X, Shi R, Wei X, Ren S, Yan C, Ding Y, Lin Y, Fan D, Yang M, et al: PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR-counterpart K562/A02 through producing reactive oxygen species. Eur J Pharmacol. 718:459–468. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Liu Y, Li H, Wei C, Mao A, Liu W and Pan G: Polyphyllin D induces apoptosis and protective autophagy in breast cancer cells through JNK1-Bcl-2 pathway. J Ethnopharmacol. 282:1145912022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Yadav AK, Han JY, Ahn KS and Jang BC: Anti-Growth, Anti-angiogenic, and pro-apoptotic effects by CX-4945, an inhibitor of casein kinase 2, on HuCCT-1 human cholangiocarcinoma cells via control of caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α. Int J Mol Sci. 23:63532022. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Z, Ding J and Xiao X: Salvianolic acid a induces apoptosis and inhibits the C-Met expression in hepatocellular carcinoma HepG2 cell line. Chin J Mod Appl Pharm. 31:537–541. 2014. | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Seront E, Pinto A, Bouzin C, Bertrand L, Machiels JP and Feron O: PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation. Br J Cancer. 109:1586–1592. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sun B, Zhao Y, Yang S, Li X, Li N, Wang Y, Han Q, Liu X, Tu Q, Zheng J and Zhang X: Celecoxib as a potential treatment for hepatocellular carcinoma in populations exposed to high PFAS levels. J Hazard Mater. 489:1376132025. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Bian X, Zhang C, Chen Y, Huang S, Zhao S and Li Y: Identifying prognostic biomarkers and immune interactions in ovarian cancer associated with perfluorooctanoic acid exposure: Insights from comparative toxicogenomics and molecular docking studies. Ecotoxicol Environ Saf. 291:1178312025. View Article : Google Scholar : PubMed/NCBI | |
|
Hu M, Tao P, Wang Y, Zhu C, Ma Y, Liu X and Cai H: Knockdown of CCNB2 inhibits the tumorigenesis of gastric cancer by regulation of the PI3K/Akt pathway. Sci Rep. 15:57032025. View Article : Google Scholar : PubMed/NCBI | |
|
Noorolyai S, Shajari N, Baghbani E, Sadreddini S and Baradaran B: The relation between PI3K/AKT signalling pathway and cancer. Gene. 698:120–128. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bi L, Chen J, Yuan X, Jiang Z and Chen W: Salvianolic acid A positively regulates PTEN protein level and inhibits growth of A549 lung cancer cells. Biomed Rep. 1:213–217. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wülfing P, Kersting C, Tio J, Fischer RJ, Wülfing C, Poremba C, Diallo R, Böcker W and Kiesel L: Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res. 10:2393–2400. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Wang S, Yu Y, Sun S, Zhang Y, Zhang Y, Yang W, Li S and Qiao Y: Salvianolic acid A, as a novel ETA receptor antagonist, shows inhibitory effects on tumor in vitro. Int J Mol Sci. 17:12442016. View Article : Google Scholar : PubMed/NCBI | |
|
Leng X, Kan H, Wu Q, Li C, Zheng Y and Peng G: Inhibitory effect of Salvia miltiorrhiza extract and its active components on cervical intraepithelial neoplastic cells. Molecules. 27:15822022. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Fang J, Si T, Lu Y and Jiang L: Salvianolic acid A inhibits the growth of diffuse large B-cell lymphoma through MAPK pathways. Exp Hematol. 94:60–68.e2. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li HY, Li Y, Yan CH, Li LN and Chen XG: Inhibition of tumor growth by S-3-1, a synthetic intermediate of salvianolic acid A. J Asian Nat Prod Res. 4:271–280. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Xuan Z, Zhang Y, Li D, Wang K, Huang P and Shi J: PLXNB1/SEMA4D signals mediate interactions between malignant epithelial and immune cells to promote colorectal cancer liver metastasis. J Cell Mol Med. 28:e701422024. View Article : Google Scholar : PubMed/NCBI | |
|
Xie S, Han S, Gong J, Feng Z, Sun Y, Yao H and Shi P: Bee venom prompts the inhibition of gefitinib on proliferation, migration, and invasion of non-small cell lung cancer cells via EGFR-mediated autophagy. Toxicon. 251:1081492024. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Sun Y, Guo J, Cheng Y, Lu W, Yang W, Wang L and Cheng Z: Sodium bicarbonate potentiates the antitumor effects of Olaparib in ovarian cancer via cGMP/PKG-mediated ROS scavenging and M1 macrophage transformation. Biomed Pharmacother. 180:1175092024. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta GP and Massagué J: Cancer metastasis: Building a framework. Cell. 127:679–695. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Liu L, Meng T, Zheng X, Liu Y, Hao R, Yan Y, Chen S, You H, Xing J and Dong Y: Transgelin 2 promotes paclitaxel resistance, migration, and invasion of breast cancer by directly interacting with PTEN and activating PI3K/Akt/GSK-3β pathway. Mol Cancer Ther. 18:2457–2468. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fares J, Fares MY, Khachfe HH, Salhab HA and Fares Y: Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct Target Ther. 5:282020. View Article : Google Scholar : PubMed/NCBI | |
|
Mrozik KM, Blaschuk OW, Cheong CM, Zannettino ACW and Vandyke K: N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer. 18:9392018. View Article : Google Scholar : PubMed/NCBI | |
|
Saldanha R, Ho Thanh MT, Krishnan N, Hehnly H and Patteson A: Vimentin supports cell polarization by enhancing centrosome function and microtubule acetylation. J R Soc Interface. 21:202306412024. View Article : Google Scholar : PubMed/NCBI | |
|
Xypolita ME, Goolam M, Bikoff EK, Robertson EJ and Mould AW: The zinc-finger transcription factor Blimp1/Prdm1 is required for uterine remodelling and repair in the mouse. Nat Commun. 16:12202025. View Article : Google Scholar : PubMed/NCBI | |
|
Curran S and Murray GI: Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tong Z, Zhang Y, Guo P, Wang W, Chen Q, Jin J, Liu S, Yu C, Mo P, Zhang L and Huang J: Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9. J Cell Mol Med. 28:e181712024. View Article : Google Scholar : PubMed/NCBI | |
|
Li K, Li D, Hafez B, Bekhit MMS, Jardan YAB, Alanazi FK, Taha EI, Auda SH, Ramzan F and Jamil M: Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC). Oncol Res. 32:737–752. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Guo J, Song Z, Muming A, Zhang H and Awut E: Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway. Naunyn Schmiedebergs Arch Pharmacol. 397:6051–6059. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Chuang CY, Ho YC, Lin CW, Yang WE, Yu YL, Tsai MC, Yang SF and Su SC: Salvianolic acid A suppresses MMP-2 expression and restrains cancer cell invasion through ERK signaling in human nasopharyngeal carcinoma. J Ethnopharmacol. 252:1126012020. View Article : Google Scholar : PubMed/NCBI | |
|
Stasiak P, Sopel J, Lipowicz JM, Rawłuszko-Wieczorek AA, Korbecki J and Januchowski R: The role of elacridar, a P-gp inhibitor, in the Re-sensitization of PAC-resistant ovarian cancer cell lines to cytotoxic drugs in 2D and 3D cell culture models. Int J Mol Sci. 26:11242025. View Article : Google Scholar : PubMed/NCBI | |
|
Nikolaou M, Pavlopoulou A, Georgakilas AG and Kyrodimos E: The challenge of drug resistance in cancer treatment: A current overview. Clin Exp Metastasis. 35:309–318. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jin Q, Ren Q, Chang X, Yu H, Jin X, Lu X, He N and Wang G: Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer. J Cancer. 12:3648–3659. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yao S, Liu X, Feng Y, Li Y, Xiao X, Han Y and Xia S: Unveiling the role of HGF/c-Met signaling in Non-small cell lung cancer tumor microenvironment. Int J Mol Sci. 25:91012024. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Liu S, Yang X, Cao S and Zhou Y: Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Life Sci. 263:1185232020. View Article : Google Scholar : PubMed/NCBI | |
|
Shao Z, Pan H, Tu S, Zhang J, Yan S and Shao A: HGF/c-Met Axis: The advanced development in digestive system cancer. Front Cell Dev Biol. 8:8012020. View Article : Google Scholar : PubMed/NCBI | |
|
Bahrami A, Shahidsales S, Khazaei M, Ghayour-Mobarhan M, Maftouh M, Hassanian SM and Avan A: C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives. J Cell Physiol. 232:2657–2673. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Pilotto S, Carbognin L, Karachaliou N, Ma PC, Rosell R, Tortora G and Bria E: Tracking MET de-addiction in lung cancer: A road towards the oncogenic target. Cancer Treat Rev. 60:1–11. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu JC, Wang CT, Hung HC, Wu WJ, Wu DC, Chang MC, Sung PJ, Chou YW, Wen ZH and Tai MH: Heteronemin is a Novel c-Met/STAT3 inhibitor against advanced prostate cancer cells. Prostate. 76:1469–1483. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, Wu Y, Li X, Li X, Li G, et al: Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. Mol Cancer. 17:452018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen FY, Bi L, Qian L, Gao J, Jiang YC and Chen WP: Identification of multidrug resistance gene MDR1 associated microRNA of salvianolic acid A reversal in lung cancer. Zhongguo Zhong Yao Za Zhi. 41:3279–3284. 2016.(In Chinese). PubMed/NCBI | |
|
Li H, Chen J, Xu C, Pang L and Cheng X: Antitumor effect of salvianolic acid A and on its reversal of multidrug resisitance in A549/MTX tumor. Chin J Clin Pharmacol Ther. 22:12442017. | |
|
Ye T, Chen R, Zhou Y, Zhang J, Zhang Z, Wei H, Xu Y, Wang Y and Zhang Y: Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) pathway. Bioengineered. 13:11646–11655. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Zhang Y, Dang W, Xing B, Yu C, Guo P, Pi J, Deng X, Qi D and Liu Z: The anti-tumor and renoprotection study of E-[c(RGDfK)(2)]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A. J Nanobiotechnology. 20:4252022. View Article : Google Scholar : PubMed/NCBI | |
|
Xue L, Ouyang W, Qi P, Zhu Y, Qi X, Zhang X, Zhang X, Wang L and Cui L: Key mechanisms of angiogenesis in the infarct core: Association of macrophage infiltration with venogenesis. Mol Brain. 18:122025. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Yan and Yuan E: Regulatory effect of N6-methyladenosine on tumor angiogenesis. Front Immunol. 15:14537742024. View Article : Google Scholar : PubMed/NCBI | |
|
Sayed ZS, Khattap MG, Madkour MA, Yasen NS, Elbary HA, Elsayed RA, Abdelkawy DA, Wadan AS, Omar I and Nafady MH: Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature. Discov Oncol. 15:942024. View Article : Google Scholar : PubMed/NCBI | |
|
Lugano R, Ramachandran M and Dimberg A: Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cell Mol Life Sci. 77:1745–1770. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jin R, Neufeld L and McGaha TL: Linking macrophage metabolism to function in the tumor microenvironment. Nat Cancer. 6:239–252. 2025. View Article : Google Scholar : PubMed/NCBI | |
|
Bergers G and Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lim JX, Yong YK, Dewi FRP, Chan SY and Lim V: Nanoscale strategies: Doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches. Drug Deliv Transl Res. February 15–2025.(Epub ahead of print). View Article : Google Scholar | |
|
Qian C, Zhou Y, Zhang T, Dong G, Song M, Tang Y, Wei Z, Yu S, Shen Q, Chen W, et al: Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery. Acta Pharm Sin B. 14:2077–2096. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Kaur T, Weadick B, Mace TA, Desai K, Odom H and Govindarajan R: Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. Pharmacol Ther. 240:1083002022. View Article : Google Scholar : PubMed/NCBI | |
|
Tang C, Jiang ST, Li CX, Jia XF and Yang WL: The Effect of salvianolic acid a on Tumor-associated macrophage polarization and its mechanisms in the tumor microenvironment of Triple-negative breast cancer. Molecules. 29:14692024. View Article : Google Scholar : PubMed/NCBI | |
|
Nan Y, Wu X, Luo Q, Chang W, Zhao P, Zhang L and Liu Z: OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proc Natl Acad Sci USA. 121:e23153481212024. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Zhao J, Liu F, Xie Z, Lei X, Wang Z, Yang Z, Zhou Y and Tang G: A Smart CA IX-targeting and pH-responsive nano-mixed micelles for delivery of FB15 with superior anti-breast cancer efficacy. Int J Nanomedicine. 19:10247–10262. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang C, Pan Y, Cai R, Guo S, Zhang X, Xue Y, Wang J, Huang J, Wang J, Gu Y and Zhang Z: Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis. Neuropharmacology. 167:1079802020. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu C, Zhang JZ, Wu B, Xu CC, Pang HH, Tu QC, Lu YQ, Guo QY, Xia F and Wang JG: Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines. J Nanobiotechnology. 21:4562023. View Article : Google Scholar : PubMed/NCBI | |
|
Lu L, Zhang H, Qian Y and Yuan Y: Isolation of salvianolic acid A, a minor phenolic carboxylic acid of Salvia miltiorrhiza. Nat Prod Commun. 5:805–808. 2010.PubMed/NCBI | |
|
Yang MY, Liu Y, Yu YW, Gong BF, Ruan J and Fan HY: Application of targeted liposomes-based salvianolic acid A for the treatment of ischemic stroke. Neurotherapeutics. 21:e003422024. View Article : Google Scholar : PubMed/NCBI |
